Table: Sawai Pharmaceutical -2017/18 group forecast(IFRS)
Feb 13 (Reuters) -
Sawai Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2018 Mar 31, 2018
LATEST PREVIOUS
FORECAST FORECAST
Sales 168.80 168.80
Operating 23.70 23.70
PreTax 23.30 23.30
Net 12.80 17.30
EPS Basic 343.59 yen 464.39 yen
NOTE - Sawai Pharmaceutical Co Ltd.(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)